An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration date
Advances in the Management of Classical Hodgkin Lymphoma 0.50 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Perioperative Management of Anticoagulation and Antithrombotic Therapy 0.50 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Updates in the Management of Mantle Cell Lymphoma: Is There Still a Role for Transplant? 1.00 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Relapsed/Refractory CLL/SLL: Overcoming Resistance to Covalent BTKi and/or BCL2 Inhibitors 0.50 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Management of Toxicities of BTK Inhibitors in B-Cell Malignancies 0.75 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Bone Disease Management and Infections in Multiple Myeloma 1.00 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Chronic Myeloid Leukemia/Myelofibrosis: TKI Therapy and Toxicity Management 0.75 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Management of Graft-Versus-Host Disease in Hematopoietic Cell Transplant Recipients 0.50 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Management of Lower-Risk Myelodysplastic Syndromes 0.50 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Management of Waldenström Macroglobulinemia 0.50 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Updates in the Management of Myelofibrosis 0.50 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Archived Monthly Oncology Tumor Boards: Management of Recurrent/Metastatic Cervical Cancer and Neuroendocrine Carcinoma of the Cervix 1.00 12/05/2023 - 12:00am to 12/05/2024 - 12:00am
Archived Monthly Oncology Tumor Boards: Management of Advanced Ovarian Cancer 1.00 12/09/2023 - 12:00am to 12/09/2024 - 12:00am
NCCN Guidelines® Insights - Cervical Cancer, Version 1.2024 1.00 12/10/2023 - 12:00am to 12/10/2024 - 12:00am
Immunotherapy in Hepatocellular Carcinoma: Improving the Treatment Paradigm Within Community Practice 1.00 12/19/2023 - 12:00am to 12/19/2024 - 12:00am

Pages